MEG3 and liver cancer: However, MEG3 plus β-catenin did not significantly alter the BrdU positive rate of liver cancer cells (56.43 ± 13.27% versus 52.4 ± 10.71%, P = 0.3793616 >0.05) (Fig. 11c).